Pinz Capital Management’s ImageneBio Inc IMA Stock Holding History

Pinz Capital Management’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,116	Closed	-$356K	–	253
2021 Q2	$356K	Buy	+2,116	New	+$467K	0.11%	96

Other funds holding IMA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pinz Capital Management's IMA Position: Q3 2021 in Review

Pinz Capital Management sold out of ImageneBio Inc (IMA) in Q3 2021, closing a stake of 2,116 shares — an estimated $356K sold.

Pinz Capital Management first reported a position in IMA in Q2 2021 and held it in 1 quarter. The position peaked at $356K in Q2 2021. 39 funds tracked by Wall St. Rank hold IMA as of Q3 2021.

Pinz Capital Management reported no remaining ImageneBio Inc position as of Q3 2021 after selling out during the quarter.
Pinz Capital Management sold 2,116 ImageneBio Inc shares in Q3 2021, an estimated $356K.
Pinz Capital Management first reported a position in ImageneBio Inc in Q2 2021 and held it in 1 quarter.
Pinz Capital Management's ImageneBio Inc position peaked at $356K in Q2 2021.
39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2021.

Based on Pinz Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.